About the Ophthalmic Cancers Session
Ophthalmic cancers, though rare, present significant challenges in both diagnosis and treatment. These malignancies can affect various parts of the eye, including the retina, iris, and surrounding tissues. Research in this field focuses on improving early detection methods such as advanced imaging techniques and genetic screening to identify high-risk individuals. Additionally, there's a growing emphasis on developing targeted therapies tailored to the specific genetic mutations driving these cancers. Collaborative efforts between ophthalmologists, oncologists, and researchers aim to unravel the intricate biology of these tumors and devise more effective treatment strategies, ultimately improving outcomes and quality of life for patients with ophthalmic cancers.
Topics Covered in Ophthalmic Cancers
Choroidal Melanoma
Ocular Surface Neoplasia
Eyelid Carcinomas
Intraocular Lymphoma
Orbital Tumors
Germline Testing
Related Scientific Sessions at CIOC 2027
Why Attend the Ophthalmic Cancers Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Ophthalmic Cancers work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Ophthalmic Cancers research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Ophthalmic Cancers track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Ophthalmic Cancers Conference 2027 — FAQs
What is the Ophthalmic Cancers track at CIOC 2027?
The Ophthalmic Cancers track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Ophthalmic Cancers. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Ophthalmic Cancers sessions?
Cancer researchers and clinicians, educators and students with an interest in Ophthalmic Cancers are all welcome — whether presenting or attending.
Can I present my research in the Ophthalmic Cancers track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Ophthalmic Cancers sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Ophthalmic Cancers track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.